Condition
Cannabis Use Disorders
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Completed1
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07523633Phase 2Not Yet Recruiting
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
NCT00613405Not ApplicableCompletedPrimary
Stress and Marijuana Cue-elicited Craving and Reactivity
NCT00673647Phase 3UnknownPrimary
CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS
Showing all 3 trials